[go: up one dir, main page]

DK0465913T3 - Diaminotrifluormethylpyridinderivater, fremgangsmåder til fremstilling deraf og phospholipase-A2-inhibitor indeholdende samme - Google Patents

Diaminotrifluormethylpyridinderivater, fremgangsmåder til fremstilling deraf og phospholipase-A2-inhibitor indeholdende samme

Info

Publication number
DK0465913T3
DK0465913T3 DK91110421.4T DK91110421T DK0465913T3 DK 0465913 T3 DK0465913 T3 DK 0465913T3 DK 91110421 T DK91110421 T DK 91110421T DK 0465913 T3 DK0465913 T3 DK 0465913T3
Authority
DK
Denmark
Prior art keywords
substituted
alkyl
independent
another
phenyl
Prior art date
Application number
DK91110421.4T
Other languages
English (en)
Inventor
Takahiro Haga
Hideo Sugi
Itaru Shigehara
Shinji Odawara
Syuichi Yotsuya
Hirohiko Kimura
Kazuhiro Yamamoto
Original Assignee
Ishihara Sangyo Kaisha
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP3222530A external-priority patent/JPH05170742A/ja
Application filed by Ishihara Sangyo Kaisha filed Critical Ishihara Sangyo Kaisha
Application granted granted Critical
Publication of DK0465913T3 publication Critical patent/DK0465913T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/75Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/76Nitrogen atoms to which a second hetero atom is attached
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D453/00Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK91110421.4T 1990-07-10 1991-06-24 Diaminotrifluormethylpyridinderivater, fremgangsmåder til fremstilling deraf og phospholipase-A2-inhibitor indeholdende samme DK0465913T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP18199990 1990-07-10
JP3222530A JPH05170742A (ja) 1991-05-24 1991-05-24 ジアミノトリフルオロメチルピリジン誘導体、それらの製造方法及びそれらを含有するホスホリパーゼ▲a2▼阻害剤

Publications (1)

Publication Number Publication Date
DK0465913T3 true DK0465913T3 (da) 1997-10-20

Family

ID=26500966

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91110421.4T DK0465913T3 (da) 1990-07-10 1991-06-24 Diaminotrifluormethylpyridinderivater, fremgangsmåder til fremstilling deraf og phospholipase-A2-inhibitor indeholdende samme

Country Status (13)

Country Link
EP (1) EP0465913B1 (da)
JP (3) JP3078896B2 (da)
KR (1) KR0173311B1 (da)
CN (1) CN1032534C (da)
AT (1) ATE157969T1 (da)
AU (1) AU642267B2 (da)
CA (1) CA2045857C (da)
DE (1) DE69127595T2 (da)
DK (1) DK0465913T3 (da)
ES (1) ES2107434T3 (da)
GR (1) GR3025455T3 (da)
IL (1) IL98762A (da)
NZ (1) NZ238752A (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0465913T3 (da) 1990-07-10 1997-10-20 Ishihara Sangyo Kaisha Diaminotrifluormethylpyridinderivater, fremgangsmåder til fremstilling deraf og phospholipase-A2-inhibitor indeholdende samme
GB9403333D0 (en) * 1994-02-22 1994-04-13 Zeneca Ltd Compound and use
FR2720396B1 (fr) * 1994-05-27 1996-06-28 Adir Nouveaux N-pyridyl carboxamides et dérivés leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
ID18983A (id) * 1996-12-04 1998-05-28 Lilly Co Eli Pirazola sebagai inhibitor sekresi fosfolipase a2 non-pankreas pada manusia
ZA981430B (en) * 1997-02-28 1998-08-24 Ishihara Sangyo Kaisha Anticancer composition
JP4848091B2 (ja) * 2000-01-31 2011-12-28 石原産業株式会社 ジアミノトリフルオロメチルピリジン誘導体を含有する消化器疾患治療剤又は予防剤
JP2001288089A (ja) * 2000-02-01 2001-10-16 Ishihara Sangyo Kaisha Ltd ジアミノトリフルオロメチルピリジン誘導体を含有する肝疾患の治療剤又は予防剤
JP4848092B2 (ja) * 2000-02-01 2011-12-28 石原産業株式会社 ジアミノトリフルオロメチルピリジン誘導体を含有する肺不全の治療剤又は予防剤
EP1252891B1 (en) * 2000-02-01 2005-10-05 Ishihara Sangyo Kaisha, Ltd. Use of DIAMINOTRIFLUOROMETHYLPYRIDINE DERIVATIVES FOR the prevention and treatment of LIVER DISEASES
AU2003277537A1 (en) * 2002-10-30 2004-05-25 Ishihara Sangyo Kaisha, Ltd. REGULATION OF INTERACTION BETWEEN RAPL AND Rap1
JP5584518B2 (ja) 2009-05-28 2014-09-03 石原産業株式会社 ジアミノトリフルオロメチルピリジン誘導体を含有する抗ショック剤
EP2923710A1 (en) 2014-03-27 2015-09-30 Universitätsklinikum Heidelberg Bacterial phospholipase inhibitors as modulator of colonic bacterial flora
US20200289481A1 (en) 2017-11-02 2020-09-17 Ishihara Sangyo Kaisha, Ltd. Sustained-release pharmaceutical composition
MX2020008992A (es) * 2018-03-01 2020-09-28 Ishihara Sangyo Kaisha Composicion farmaceutica con excelente estabilidad en almacenamiento.
US12473259B2 (en) 2019-05-15 2025-11-18 Ishihara Sangyo Kaisha, Ltd. Anhydrous crystal of monosodium n-(2-ethylsulfonylamino-5-trifluoromethyl-3-pyridyl)cyclohexane carboxamide
KR102188659B1 (ko) 2019-12-10 2020-12-08 박영식 핸드 파렛트 트럭용 전도방지장치
WO2022071233A1 (ja) * 2020-09-29 2022-04-07 石原産業株式会社 優れた保存効力を示す液状医薬組成物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3962263A (en) 1970-03-20 1976-06-08 Eli Lilly And Company N-(2,2-difluoroalkanoyl)-2,3-pyridinediamine compounds
FR2124163A1 (en) * 1971-02-10 1972-09-22 Ferlux 2-amino-3-hydroxypyridine derivs - cardiovascular active
US3963660A (en) * 1973-10-04 1976-06-15 The Upjohn Company Pyridine dioxamic acids and esters
US3961063A (en) 1975-04-03 1976-06-01 Smithkline Corporation 2,3-Bis-(3-acyl-2-thioureido)-pyridines
DK0465913T3 (da) * 1990-07-10 1997-10-20 Ishihara Sangyo Kaisha Diaminotrifluormethylpyridinderivater, fremgangsmåder til fremstilling deraf og phospholipase-A2-inhibitor indeholdende samme

Also Published As

Publication number Publication date
CA2045857A1 (en) 1992-01-11
DE69127595D1 (de) 1997-10-16
HK1001839A1 (en) 1998-07-10
GR3025455T3 (en) 1998-02-27
IL98762A0 (en) 1992-07-15
CN1058396A (zh) 1992-02-05
KR920002546A (ko) 1992-02-28
ES2107434T3 (es) 1997-12-01
AU642267B2 (en) 1993-10-14
JP3078896B2 (ja) 2000-08-21
EP0465913A3 (en) 1992-04-15
JP3048344B2 (ja) 2000-06-05
JPH06263735A (ja) 1994-09-20
JPH06247934A (ja) 1994-09-06
IL98762A (en) 1995-05-26
CA2045857C (en) 1997-09-23
EP0465913A2 (en) 1992-01-15
DE69127595T2 (de) 1998-01-22
JPH10152473A (ja) 1998-06-09
KR0173311B1 (ko) 1999-02-01
CN1032534C (zh) 1996-08-14
NZ238752A (en) 1993-06-25
AU7949791A (en) 1992-01-16
JP2762323B2 (ja) 1998-06-04
EP0465913B1 (en) 1997-09-10
ATE157969T1 (de) 1997-09-15

Similar Documents

Publication Publication Date Title
DK0465913T3 (da) Diaminotrifluormethylpyridinderivater, fremgangsmåder til fremstilling deraf og phospholipase-A2-inhibitor indeholdende samme
ES2085118T3 (es) Amidas de piridinas y sus sales, procedimiento para su preparacion y composiciones que las contienen
DK66888D0 (da) Fungicider og fremgangsmaade til fremstilling heraf
DE3882382D1 (de) Verfahren zur termitenbekaempfung.
DK567089D0 (da) Diazacycloalkanderivater
RU93004941A (ru) Способ борьбы с нематодами
NO902657L (no) N-fenylpyrazolderivater, preparater og anvendelse derav.
DE60113808D1 (de) Therapeutikum oder Prophylaktikum für Lebererkrankungen, enthaltend ein Diaminotrifluorethylpyridin-Derivat
DE3667788D1 (de) Diphenyletherherbizide.
ATE96776T1 (de) Glycinverbindungen.
MX9304249A (es) Derivados de n-acildihidroquinolina, metodo para su produccion y composiciones herbicidas que los contienen.
ES8507102A1 (es) Procedimiento de preparacion de derivados de acidos fenoxibenzoicos
DE69021744D1 (de) Oximinetherderivate.